Donald Notman - Net Worth and Insider Trading
Donald Notman Net Worth
The estimated net worth of Donald Notman is at least $2 Million dollars as of 2024-12-01. Donald Notman is the CFO of Ocular Therapeutix Inc and owns about 195,356 shares of Ocular Therapeutix Inc (OCUL) stock worth over $2 Million. Details can be seen in Donald Notman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Donald Notman has not made any transactions after 2024-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Donald Notman
Donald Notman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Donald Notman owns 1 companies in total, including Ocular Therapeutix Inc (OCUL) .
Click here to see the complete history of Donald Notman’s form 4 insider trades.
Insider Ownership Summary of Donald Notman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2024-02-05 | Chief Financial Officer |
Donald Notman Latest Holdings Summary
Donald Notman currently owns a total of 1 stock. Donald Notman owns 195,356 shares of Ocular Therapeutix Inc (OCUL) as of February 5, 2024, with a value of $2 Million.
Latest Holdings of Donald Notman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2024-02-05 | 195,356 | 9.89 | 1,932,071 |
Holding Weightings of Donald Notman
Donald Notman Form 4 Trading Tracker
According to the SEC Form 4 filings, Donald Notman has made a total of 3 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Ocular Therapeutix Inc is the sale of 6,212 shares on February 5, 2024, which brought Donald Notman around $30,190.
Insider Trading History of Donald Notman
- 1
Donald Notman Trading Performance
GuruFocus tracks the stock performance after each of Donald Notman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald Notman is 10.15%. GuruFocus also compares Donald Notman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald Notman within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Donald Notman's insider trading performs compared to the benchmark.
Performance of Donald Notman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.83 | | | | | |
| Relative Return to S&P 500(%) | 9.26 | | | | | |
Donald Notman Ownership Network
Donald Notman Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Donald Notman is the Chief Financial Officer of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Donald Notman made 2 insider transaction in Ocular Therapeutix Inc (OCUL) with a net sale of 12,645. Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 63,186 shares made by Pravin Dugel , a net sale of 31,480 shares made by Antony C. Mattessich , and a net sale of 14,942 shares made by Rabia Gurses Ozden .
In summary, during the past 3 months, insiders sold 28,339 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 28,339 shares. During the past 18 months, 164,435 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,311,377 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Donald Notman Mailing Address
Above is the net worth, insider trading, and ownership report for Donald Notman. You might contact Donald Notman via mailing address: C/o Ocular Therapeutix, Inc., 15 Crosby Drive, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
